Sinoway Industrial Co., Ltd.
Products
Updates

Dapagliflozin 461432-26-8 Dapagliflozin 461432-26-8

Dapagliflozin 461432-26-8
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

    + detail
  • NanoActive Astaxanthin 472-61-7

    NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

    + detail
  • NanoActive Curcumin 458-37-7

    NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

    + detail
Contact Us

Basic information of Dapagliflozin:

Name

Dapagliflozin

Alias

Bms 512148; BMS5121458; DAPAGLIFLOZIN;B MS-512148-05; Dag coluMn net; Dapagliflozin, >=98%; Dapagliflozin(BMS-512148); Dapagliflozin propanediol; Dapagliflozin Isomer Impurity; Dapagliflozin S1548 Selleck

CAS NO.

461432-26-8

Molecular Formula

 C21H25ClO6

Molecular Weight

 408.8726

Grade Standard

Medicine grade  / 99% min / GMP application / PMDA / DMF

Package Size

25kg/drum

Storage:

Keep in a well-closed container, protected from light and stored at a temperature of 2 to 8


Use of Dapagliflozin:

Dapagliflozin works through a non-insulin-dependent mechanism to reduce blood sugar by reducing glucose in the kidneys and directly from the urine. At the same time, weight loss and blood pressure drop are found at the secondary endpoint of the dapagliflozin study. Indications: Based on diet and exercise, this product can be used as a monotherapy for adult patients with type 2 diabetes to improve glycemic control. This product is not suitable for the treatment of type 1 diabetes or diabetic ketoacidosis.

COA of Dapagliflozin:

ITEMS

STANDARDS

RESULTS

Appearance

White powder

Complies

Identification

HPLC/NMR

Complies

Purity

Not less than 99.5%

99.85%

Assay

98.0-102.0%

99.2%

Individual impurity

Not more than 0.1%

0.04%

Total impurity

≤0.5%

0.15

Particle size distribution

D90<75μm

Complies

Residue on ignition

≤0.1%

Complies

Heavy metals

≤20ppm

Complies

Melting point

71-78℃

73.2-74.5℃

Isomer

≤0.15%

N/A

Percentage of Propanediol

13.6%~16.6%

14.3%

Water

3.0%-4.4%

3.8%

Loss on drying

≤1.0%

Complies

Optical rotation

+13° to +17°

Complies


  • Metformin 657-24-9
    Basic information of Metformin:NameMetforminMolecular FormulaC4H11N5Molecular Weight129.16Quality StandardEP/USP/BPPackage Size25kg/drumBrief IntroductionMetformin, marketed under the tradename Glucop... Metformin 657-24-9
  • Sitagliptin Phosphate 654671-78-0/654671-77-9
    Basic information of Sitagliptin:NameSitagliptinMolecular FormulaC16H15F6N5OMolecular Weight407.32 Quality StandardIn housePackage Size1kg/bag or according your requirementBrief IntroductionThis drug... Sitagliptin Phosphate 654671-78-0/654671-77-9
  • Galantamine 357-70-0
    Basic information of GalantamineNameGalantamineAliasGalantamine hydrobromCAS Number357-70-0Molecular FormulaC17H21NO3Molecular Weight287.35Quality StandardIn housePackage Size5kg/bag, 10kg/bag, accord... Galantamine 357-70-0
  • Lacosamide 175481-36-4
    Basic information of Lacosamide :NameLacosamideAlias(2R)-2-acetamido-N-benzyl-3-methoxy-propanamide;(2R)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide;ADD 243037;Erlosamide;Harkoseride;SPM 927... Lacosamide 175481-36-4

MORE_DETAIL Dapagliflozin 461432-26-8

Basic information of Dapagliflozin:

Name

Dapagliflozin

Alias

Bms 512148; BMS5121458; DAPAGLIFLOZIN;B MS-512148-05; Dag coluMn net; Dapagliflozin, >=98%; Dapagliflozin(BMS-512148); Dapagliflozin propanediol; Dapagliflozin Isomer Impurity; Dapagliflozin S1548 Selleck

CAS NO.

461432-26-8

Molecular Formula

 C21H25ClO6

Molecular Weight

 408.8726

Grade Standard

Medicine grade  / 99% min / GMP application / PMDA / DMF

Package Size

25kg/drum

Storage:

Keep in a well-closed container, protected from light and stored at a temperature of 2 to 8


Use of Dapagliflozin:

Dapagliflozin works through a non-insulin-dependent mechanism to reduce blood sugar by reducing glucose in the kidneys and directly from the urine. At the same time, weight loss and blood pressure drop are found at the secondary endpoint of the dapagliflozin study. Indications: Based on diet and exercise, this product can be used as a monotherapy for adult patients with type 2 diabetes to improve glycemic control. This product is not suitable for the treatment of type 1 diabetes or diabetic ketoacidosis.

COA of Dapagliflozin:

ITEMS

STANDARDS

RESULTS

Appearance

White powder

Complies

Identification

HPLC/NMR

Complies

Purity

Not less than 99.5%

99.85%

Assay

98.0-102.0%

99.2%

Individual impurity

Not more than 0.1%

0.04%

Total impurity

≤0.5%

0.15

Particle size distribution

D90<75μm

Complies

Residue on ignition

≤0.1%

Complies

Heavy metals

≤20ppm

Complies

Melting point

71-78℃

73.2-74.5℃

Isomer

≤0.15%

N/A

Percentage of Propanediol

13.6%~16.6%

14.3%

Water

3.0%-4.4%

3.8%

Loss on drying

≤1.0%

Complies

Optical rotation

+13° to +17°

Complies

Leave a Message Email Us

We will contact you within 24 hours.

  • TEL:+86-0592-5853819
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//